More
Topics
Acne
Cosmetic
Eczema
Infections
Pediatric
Practice Management
Psoriasis
Residents
Rosacea
Skin Cancer
Skin of Color
Advertisement
Neal Bhatia, MD, FAAD
Think twice about slashing or eliminating budgets for marketing. It is an essential lifeline for financial recovery.
Naren Arulrajah
Adjusting your practice for the COVID-19 crisis and beyond.
Michele Simmons, and Glenn Morley
What history can tell us about investing during the COVID-19 crisis.
David B. Mandell, JD, MBA, and Adam Braunscheidel, CFP
Despite focus on the clinical consequences of overusing antibiotics for decades, relatively little has been said about the potential impact on the microbiome.
Sourab Choudhury, DO
Encourage patients to keep up with skincare and prescription regimens and be prepared to offer in-office procedures when appropriate.
Jennifer Deaver Peterson, MD, FAAD
Telederm may not be ideal, but it is essential for acne and rosacea patients today—and could persist in the future.
Michael Gold, MD, FAAD
Zoe Diana Draelos, MD
There is plenty of uncertainty for most dermatology practices, but communicating with advanced staff about what is known can be important.
Kasey D’Amato, PA-C, and Katherine Wilkens, PA-Cs
Whether you’ve never heard of it or simply forgot about it, each of these tools can improve patient care in the clinic.
Steven Leon, MS, PA-C
Experts offer suggestions to lead aesthetic medicine forward in the post- COVID-19 era.
Joel Schlessinger, MD, FAAD
While there’s no data about susceptibility to COVID-19 in psoriasis, there is relevant information on infectious complications from biologics.
Jennifer Soung, MD
Adam Friedman, MD, FAAD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.
October 2020
September 2020
August 2020
July 2020
